The Evening Wrap Welcome to the Evening Wrap newsletter, your guide to the day’s biggest stories with concise analysis from The Hindu. We hope you are staying home and staying safe. Here are the big stories that you need to follow today: FM announcements Finance Minister Nirmala Sitharaman today shared the details of the ₹20 lakh crore Covid-19 economic stimulus package announced by Prime Minister Narendra Modi yesterday. Here are the highlights: - ₹3 lakh crores worth of collateral-free, automatic loans for struggling Micro, Small and Medium Enterprises (MSMEs). Loans will have a four-year tenure and 12 month moratorium on principal repayment. Borrowers with up to ₹25 crore loan outstanding and ₹100 crore turnover are eligible. The scheme can be availed till October 31, 2020.
- As part of efforts to support Indian businesses, global tenders will be disallowed for government procurement tenders up to ₹200 crore.
- Tax deducted at source (TDS) and tax collection at source (TCS) rates reduced by 25% with effect from May 14, 2020 to March 21, 2021. This is expected to release liquidity of ₹50,000 crore.
- Deadline for filing income tax returns extended to November 30, 2020, and the last date for tax audit extended to October 31, 2020.
- A ‘fund of funds’ with a corpus of ₹10,000 will be set up to help MSMEs with growth potential.
- The three-month EPF support for businesses and employees — announced for the months of March, April and May — has been extended till August 2020. This will provide liquidity relief of ₹2,500 crore. Statutory PF contribution of both employer and employee will be reduced to 10% each (from the current 12% each) for all establishments covered by EPFO for the next three months.
- A ₹30,000 crore special liquidity scheme for non-banking finance companies (NBFCs), housing finance companies (HFCs) and micro-finance institutions (MFIs).
- Power Finance Corporation (PFC) and Rural Electrification Corporation (REC) will help infuse liquidity into fund-starved discoms (power distribution companies) by raising ₹90,000 crore against receivables.
- All contractors engaged by the government to get extensions of up to 6 months.
- In a move aimed at giving relief to builders, regulatory authorities will be asked to extend registration and completion dates for all registered projects (expiring on or after March 25) by 6 months.
Congress not impressed The Congress criticised the relief measures announced by the Finance Minister, stating that there was nothing in them for migrant workers. “There’s absolutely nothing in the measures announced by Sitharaman today for poor migrants who are walking back to their homes,” said party leader P. Chidambaram. He added that the FM had also not announced any cash transfers “for the nearly 13 crore families in the bottom half of the population who have been pushed into destitution”. 80% urban workers lose jobs We are keeping the focus on the economy in this edition of Evening Wrap, given a slew of reports indicating negative trends as a result of the lockdown. According to the Azim Premji University COVID-19 Livelihoods Survey, about 80% of urban workers lost their jobs during the lockdown. The average weekly earnings of those who were still employed fell by 61%. About 80% of urban households consumed less food in April-May compared to February, and 61% could not buy even a week’s worth of essentials. Similar effects were felt in rural areas too, though to a lesser degree. The results are based on a phone survey of 4,000 workers across 12 States. Job losses high amongst young Indians Yesterday we had referred to Centre for Monitoring Indian Economy (CMIE) data, which showed that job losses during the lockdown have been disproportionately high among younger Indians, with six crore people between the age of 20 and 39 losing jobs in April. The wider employment situation, however, has shown some improvement in the last week, on the back of a pick-up in agricultural activity and the re-opening of businesses in rural India. Factory output at record low India’s factory output plummeted to record lows in March, with the Index of Industrial Production (IIP) contracting 16.7%. This reflects the drastic impact of the countrywide lockdown that began on March 25. A positive growth of 4.5% was recorded in February. Manufacturing sector output slumped 20% in March, while electricity generation shrank almost 7%, according to data released on Tuesday by the Ministry of Statistics and Programme Implementation. “April is going to be much worse. I would project a 60-70% decline,” said Pronab Sen, eminent economist and former Chief Statistician of India. “Frankly, I don’t think most industries will see any recovery. FMCG sector may begin some recovery in May, but the rest of the industry is going to remain in the doldrums.” India may miss malnutrition targets India is among 88 countries that are likely to miss global nutrition targets that are to be met by 2025, according to the Global Nutrition Report 2020, released on Tuesday. It also identified India as the country with the highest rates of domestic inequalities in malnutrition. According to the Global Nutrition Report 2020, India will miss targets for all four nutritional indicators: stunting among under-5 children, anaemia among women of reproductive age, ensuring reduction in low birth weight and childhood overweight, and increasing the rate of exclusive breast-feeding in the first six months. In an earlier episode of the The Hindu’s In Focus podcast, we discussed how Covid-19 is disrupting other essential healthcare services. Long-term malnutrition targets being missed as a result of migrant labour not being able to send remittances home featured heavily in the discussion. Covid Watch: Numbers and Developments The number of positive coronavirus cases reported from India stands at 77,553 at the time of publishing this newsletter, with the death toll at 2,528. Globally, more than 4,272,880 infections have been reported, with at least 2,92,000 fatalities. Two pharmaceutical companies in India have signed deals with American biopharmaceutical firm Gilead Sciences for the sale of the anit-viral drug remdesivir, according to some media reports. Remdesivir was approved by the U.S. Food and Drug Administration earlier this month as a treatment for patients severely ill with Covid-19. The benefits of the drug were talked up, in particular, by the country’s foremost infectious diseases expert Dr. Anthony Fauci. The pharmaceutical firms — Jubilant Life Sciences and Hetero — signed a non-exclusive licensing agreement for selling remdesivir in 127 countries, including India. As per the agreement, companies will also get the rights to manufacture the drug and scale up production in all low-income and middle-income countries, as well as some high-income nations, according to a Reuters report. Evening Wrap will return tomorrow. | 
⇉〖OpenLoad〗 2020 Superintelligence PelÃcula Completa En LÃnea released 2020. story: La vida de Carol Peters se trastorna cuando es selecci...
Post a Comment